Skip to search boxSkip to navigationSkip to main content

Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis

  • P. Mukherjee
    ,
  • A. Dani
    ,
  • S. Bhatia
    ,
  • ,
  • A. Y. Rudensky
    ,
  • A. George
*Corresponding author for this work
  • National Institute of Immunology India
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Peptides from extracellular proteins presented on MHC class II are mostly generated and loaded in endolysosomal compartments, but the major pathways responsible for loading peptides from APC-endogenous sources on MHC class II are as yet unclear. In this study, we show that MHC class II molecules present peptides from proteins such as OVA or conalbumin introduced into the cytoplasm by hyperosmotic pinosome lysis, with efficiencies comparable to their presentation via extracellular fluid-phase endocytosis. This cytosolic presentation pathway is sensitive to proteasomal inhibitors, whereas the presentation of exogenous Ags taken up by endocytosis is not. Inhibitors of nonproteasomal cytosolic proteases can also inhibit MHC class II-restricted presentation of cytosolically delivered protein, without inhibiting MHC class I-restricted presentation from the same protein. Cytosolic processing of a soluble fusion protein containing the peptide epitope I-Eα52-68 yields an epitope that is similar to the one generated during constitutive presentation of I-Eα as an endogenous transmembrane protein, but is subtly different from the one generated in the exogenous pathway. Constitutive MHC class II-mediated presentation of the endogenous transmembrane protein I-Eα is also specifically inhibited over time by inhibitors of cytosolic proteolysis. Thus, Ag processing in the cytoplasm appears to be essential for the efficient presentation of endogenous proteins, even transmembrane ones, on MHC class II, and the proteolytic pathways involved may differ from those used for MHC class I-mediated presentation.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 2632-2641 (10 pages)

Journal (Volume, Issue Number)

Journal of Immunology (Volume 167, Issue 5)

Publication milestones

  • Published - 09/01/2001

Publication status

Published - 09/01/2001

ISSN

0022-1767

Publication IDs

  • Scopus: 0035451679
  • PubMed: 11509605

Publication metrics

Metrics

SciVal
FWCI
0.64
SciVal
Author count
9
SciVal
citations
56
SciVal
Paper percentile
87
Scopus
citations
Fractional count
1
Fractional count
0.11
Fractional count
8
Fractional count
0.89
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
58
Captures
42

Funding Details

FunderFunding number
NIAID
R01AI034206